Fig. 3.

Radiological findings after LRC. (a) Abdominal CT showed no recurrent tumor 4 months after LRC. (b) No evidence of left hydronephrosis 4 months after LRC. (c) Abdominal CT with contrast showed a 60‐mm mass at the pelvis and (d) left hydronephrosis 7.5 months after LRC. (e) Abdominal CT showed disappearance of recurrent tumor at the pelvis and (f) left hydronephrosis after two cycles of pembrolizumab therapy. (g, h) Abdominal CT with contrast showed no tumor recurrence after five cycles of pembrolizumab therapy.